There have been no reports of overdose of OHPC. In the event of overdose, treatment should be based on symptoms. OHPC has been studied in humans at high doses of 2,000 to 5,000 mg per week by intramuscular injection, without safety concerns.
Hydroxyprogesterone caproate
Hydroxyprogesterone heptanoate
Hydroxyprogesterone acetate
Estradiol enantate
Estradiol undecylate
Medroxyprogesterone acetate
Estradiol dienantate
Desoxymethyltestosterone